GLSI
Price
$12.47
Change
+$0.30 (+2.46%)
Updated
Aug 11, 04:59 PM (EDT)
Capitalization
162.83M
Earnings call today
IGC
Price
$0.36
Change
+$0.02 (+5.88%)
Updated
Aug 11, 04:59 PM (EDT)
Capitalization
28.48M
Earnings call today
Interact to see
Advertisement

GLSI vs IGC

Header iconGLSI vs IGC Comparison
Open Charts GLSI vs IGCBanner chart's image
Greenwich LifeSciences
Price$12.47
Change+$0.30 (+2.46%)
Volume$2.35K
Capitalization162.83M
IGC Pharma
Price$0.36
Change+$0.02 (+5.88%)
Volume$15.84K
Capitalization28.48M
GLSI vs IGC Comparison Chart in %
Loading...
GLSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GLSI vs. IGC commentary
Aug 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLSI is a Hold and IGC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 12, 2025
Stock price -- (GLSI: $12.18 vs. IGC: $0.34)
Brand notoriety: GLSI and IGC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLSI: 159% vs. IGC: 8%
Market capitalization -- GLSI: $166.97M vs. IGC: $29.61M
GLSI [@Biotechnology] is valued at $166.97M. IGC’s [@Biotechnology] market capitalization is $29.61M. The market cap for tickers in the [@Biotechnology] industry ranges from $96.01B to $0. The average market capitalization across the [@Biotechnology] industry is $1.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLSI’s FA Score shows that 0 FA rating(s) are green whileIGC’s FA Score has 0 green FA rating(s).

  • GLSI’s FA Score: 0 green, 5 red.
  • IGC’s FA Score: 0 green, 5 red.
According to our system of comparison, IGC is a better buy in the long-term than GLSI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLSI’s TA Score shows that 5 TA indicator(s) are bullish while IGC’s TA Score has 6 bullish TA indicator(s).

  • GLSI’s TA Score: 5 bullish, 4 bearish.
  • IGC’s TA Score: 6 bullish, 5 bearish.
According to our system of comparison, both GLSI and IGC are a good buy in the short-term.

Price Growth

GLSI (@Biotechnology) experienced а +9.83% price change this week, while IGC (@Biotechnology) price change was -0.56% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +22.22%. For the same industry, the average monthly price growth was +31.78%, and the average quarterly price growth was +19.63%.

Reported Earning Dates

GLSI is expected to report earnings on Nov 10, 2025.

IGC is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+22.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GLSI($163M) has a higher market cap than IGC($28.5M). GLSI YTD gains are higher at: 8.459 vs. IGC (1.042). IGC has higher annual earnings (EBITDA): -7.58M vs. GLSI (-16.75M). GLSI has more cash in the bank: 2.75M vs. IGC (470K). IGC has higher revenues than GLSI: IGC (1.24M) vs GLSI (0).
GLSIIGCGLSI / IGC
Capitalization163M28.5M572%
EBITDA-16.75M-7.58M221%
Gain YTD8.4591.042812%
P/E RatioN/AN/A-
Revenue01.24M-
Total Cash2.75M470K585%
Total DebtN/A270K-
FUNDAMENTALS RATINGS
IGC: Fundamental Ratings
IGC
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
48
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
56
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GLSIIGC
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
89%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
84%
Momentum
ODDS (%)
Bullish Trend 4 days ago
80%
Bearish Trend 4 days ago
85%
MACD
ODDS (%)
Bullish Trend 4 days ago
87%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
80%
Bearish Trend 4 days ago
83%
Advances
ODDS (%)
Bullish Trend 26 days ago
76%
Bullish Trend 21 days ago
83%
Declines
ODDS (%)
Bearish Trend 14 days ago
86%
Bearish Trend 5 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 6 days ago
86%
Aroon
ODDS (%)
Bullish Trend 4 days ago
62%
Bullish Trend 4 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
GLSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PEBO28.470.23
+0.81%
Peoples Bancorp
MACI10.470.01
+0.09%
Melar Acquisition Corp. I
BRBR38.99-0.17
-0.43%
BellRing Brands
TDG1389.77-39.38
-2.76%
TransDigm Group
RVPH0.41-0.02
-5.04%
Reviva Pharmaceuticals Holdings

GLSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLSI has been loosely correlated with IMNM. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if GLSI jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLSI
1D Price
Change %
GLSI100%
+4.37%
IMNM - GLSI
47%
Loosely correlated
-1.82%
ABOS - GLSI
46%
Loosely correlated
-4.23%
GBIO - GLSI
45%
Loosely correlated
-1.20%
BEAM - GLSI
45%
Loosely correlated
-1.34%
DNLI - GLSI
45%
Loosely correlated
-1.90%
More

IGC and

Correlation & Price change

A.I.dvisor indicates that over the last year, IGC has been loosely correlated with MRNA. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if IGC jumps, then MRNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IGC
1D Price
Change %
IGC100%
+0.15%
MRNA - IGC
33%
Loosely correlated
-1.84%
KZR - IGC
33%
Poorly correlated
+0.63%
ARTL - IGC
30%
Poorly correlated
-7.53%
RYTM - IGC
29%
Poorly correlated
-0.54%
GLSI - IGC
29%
Poorly correlated
+4.37%
More